Marchés français ouverture 1 h 9 min

Pharma Intelligence

ReportLinker FR

Overview This comprehensive medical market and technology report provides an overview and in-depth market analysis of the transcatheter heart valve products used in the treatment of heart valve stenosis, regurgitation, and other valvular disorders.

New York, Jan. 15, 2020 (GLOBE NEWSWIRE) -- announces the release of the report "Minimally Invasive Heart Valve Repair and Replacement Devices" -
These products include transcatheter aortic valve replacement (TAVR) systems and transcatheter mitral valve repair (TMVRep) products. In 2018, the global market for transcatheter heart valve management products, including TAVR and TMVRep products, totaled an estimated $4.2bn. During the forecast period covered by this analysis, global transcatheter heart valve management product sales are projected to grow at a compound annual growth rate (CAGR) of 9.6%, increasing to approximately $6.7bn in 2023. Geographic regions covered by this report include the US, five major EU markets (France, Germany, Italy, Spain, and the UK), Japan, and the rest of world. Market forecasts are for the 2018-23 time period.

The report provides the following useful information:

an overview of heart valve disorders
 an overview of heart valve management strategies
key statistics on heart valve procedures in major regions in the world
heart valve treatment product information
insight into developing and potentially disruptive technologies
 in-depth market and competitive analysis.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001